Stelerix Web Blog Knowledge at your Fingertips

17Feb/110

Report Giveaway – This Week Only!!

It's a $119.00 Value, for free!! We engaged over 1500 industry professionals in India and North America.

Get a thorough picture of what it takes to win in India. Forward it to your friends and get an exclusive mini-report, packed with primary research!

You can check out the Table of Contents, and download the report here!!

Posted by Jeff

15Feb/110

KOL Engagement and Alignment.

Here's a quick excerpt from our Special Comprehensive Country Report, India. It's something we've seen addressed again and again in our follow-up interviews.  I've also thrown in a YouTube interview with Tushar Barad who talks about some of the intricacies of engaging with KOLs.

The updated report will be exclusively available for free through our great friends over at pharmaphorum. So you better get registered!

"Respondents identified active engagement of local Key Opinion Leaders as the most effective means to understand their needs. Further, this strategy provides accurate insight into actual affordability as demonstrated by purchasing power and cost of living, in addition to possible commercial strategies and their respective likelihoods. However, our research also suggested that organizations as a whole have been slow to actively engage end-users. Patience and value on the long term was also a key trend among respondents. It was evident from our results that success in India favors ongoing and long-term relationships that grow and evolve over time. While short-term profit can be made, it is clear that the initial time investment and requisite patience were rewarded many times over when focus was placed on the longer term.  A further benefit of continuous investment in “relationship capital” is the evolution of mutually business partnerships. Organizations who establish themselves effectively in India can often leverage their presence to reach other fast-growing markets in the South-Asian and Asia-Pacific region. Our experts agree that to be effective into 2020 and beyond, market leaders must invest proactively in nascent relationships, given the propensity for longer cycle time in such business partnerships. Opportunity to cut costs and drive access will exist for those who look to partner and aid, rather than exploit."

Posted by Jeff

Oh yeah, the full report will also be available for download here, but this week only!!

8Feb/110

Trends in Translational Research.

Gregory Weiss was kind enough to take a few moments out of his Saturday morning to fill me in on some of the ground-breaking research he is doing at his UCI lab.

This particular clip is about his upcoming keynote remark at the Cambridge Health Institute conference, Therapeutic Approaches to Cancer Therapeutics. I will have the whole interview up soon. But for now, enjoy this!

Posted by Jeff

4Feb/110

Input in Action.

Thank you for the ongoing feedback. We are always growing, learning, and evolving. We appreciate hearing about how you think we might be able to do things a little bit better.

Today's update is regarding the library section of the main site. We've organized it into particular portals, organized by specific verticals that are of focus and interest to us. This was a change mandated by end-user input. Thanks for making our site easier to navigate and more engaging. We will continue to listen and implement your suggestions.

Check it out!

We have more changes in the pipeline and will update you here, as it happens!

Posted by Jeff

3Feb/110

Evolution

It's not like we just throw up a static web page. Our content creation initiatives are always changing, improving, evolving. And that's always based on end-user input. We pair your thoughts with out strengths and our diverse network of key opinion leaders to deliver the most cutting-edge information and technology tools in verticals of particular focus.

We do our best to engage with you, but as I said, it's a work in progress. Let us know how we can do better, please.

To help increase engagement, we're adding comment forms at the end of each new interview. You should feel encouraged to submit your thoughts, or even a follow-up question, and we'll find an answer on your behalf.

Check it out here, and here.

Posted by Jeff

2Feb/110

Health Biz India

I was lucky to get a great picture of the rapidly growing healthcare scene in India in my recent correspondence with Jayata Sharma, the Editor-in-Chief of Health Biz India.

As we've seen mentioned before, it was emphasized again that key opinion leaders are absolutely critical to progress and understanding of market conditions within India.

Inform yourself about Indian healthcare's first B2B news portal. Read this interview.

1Feb/110

Common Hurdles.

Here in Canada, we often hear about a potentially-crippling void of innovation. Closer inspection indicates that it isn't for lack of research. In fact, it's a sub-par commercialization process that is culpable for the dropped ball.

This is of course a common theme, but I was surprised to hear it mentioned to me by Kiran Mazumdar Shaw, the Managing Director of India's largest biotechnology company, Biocon. "Scientist entrepreneurs are few and far between - what challenges our scientists in advancing their research into businesses?"

And as all our research is guided by primary interactions with stakeholders, so this will be the guiding question, over the course of the next few interviews. Stay tuned for step-by-step examples of entrepreneurs who have commercialized their developments.

31Jan/110

Looking Way Ahead.

I encourage you to check out this exclusive interview. It is available to watch free on-demand. There is also a written summary if you want to get the goods quickly. I am especially excited about this conversation. I really enjoyed speaking with Vivek Shukla. His thoughts on success are an encouragement for anyone interested in self-improvement.

Going forward, based on user-input and our own intuition, this is likely the format we are going to stick with. We have improved the audio quality, and made the interview accessible for free, on-demand. There is also a Youtube clip to provide a rapid glimpse at what the entire interview holds.

We really appreciate getting input and feedback from our active users. Thanks for engaging with us. We will continue to integrate your preferences.

Posted by Jeff

28Jan/110

Value-Added Generics

I appreciate your patience in bearing with me in the last few weeks. As you undoubtedly know, I've been busy populating the library section of the main site. I am making a lot of progress, and there is even more in the pipeline.

One of the challenges has been ensuring high-quality audio. Much to my initial dismay, the sound-quality suffered on the first few recordings. For enduring this, I am grateful. After much experimentation I have found a methodology for getting things online relatively quickly and at high-fidelity.

I'm also picking out parts that I thought were of particular value. Here's a clip from Atul Sharma, talking about the importance of innovation in value-added generics.

Posted by Jeff

27Jan/110

Achieving Buy-In

I spoke with Vivek Shukla about his astounding success in pharmaceutical business strategy in India, over the last 12 years.

We talked about this success philosophy, how to leverage human capital, and how to get buy-in from stakeholders. I am working on getting the entire interview up on the main site as quickly as possible. But for now here's a little trailer. I asked Vivek what the biggest challenge was when it came to getting buy-in and alignment of vision. Enjoy!

Posted by Jeff

Page 1 of 3123